Target intelligence / Profile preview

Plasma exchange (plasmapheresis) for pathogenic antibody removal (PE (for plasma exchange), sometimes TPE (therapeutic plasma exchange))

Target
PE (for plasma exchange), sometimes TPE (therapeutic plasma exchange)
Molecular classification
Other (procedure, not a molecular target), Blood purification technique, Extracorporeal therapy
01

Overview

Plasma exchange—also known as plasmapheresis or therapeutic plasma exchange—is an extracorporeal blood purification technique designed to remove pathogenic substances such as autoantibodies, immune complexes, paraproteins, cryoglobulins, lipids, and certain toxins from the patient's plasma. The process involves separating whole blood into its cellular components and plasma using centrifugation or filtration. The plasma, which contains these harmful molecules driving disease processes in autoimmune and some neurological conditions, is discarded or treated before being replaced with substitute solutions containing albumin or fresh frozen plasma. The remaining blood cells are then returned to the patient along with this replacement fluid. This approach provides rapid reduction in circulating levels of pathological antibodies that contribute to acute exacerbations in diseases like Guillain-Barré syndrome, myasthenia gravis crisis, chronic inflammatory demyelinating polyneuropathy (CIDP), certain renal pathologies including transplant rejection episodes mediated by donor-specific antibodies, among others. It can be life-saving when conventional immunosuppressive therapies are insufficiently fast acting. While highly effective for short-term control of severe autoimmune flares by removing causative agents from circulation, it does not address underlying production mechanisms—thus repeated treatments may be necessary. Notable safety concerns include allergic reactions to replacement fluids/columns, hypotension during treatment, risk for infection at vascular access sites, and potential depletion of beneficial proteins/clotting factors. Importantly: "Pathogenic antibodies removal via plasma separation" describes a therapeutic procedure, not a discrete molecular target such as an enzyme or receptor. Therefore it should not be classified as a canonical drug target but rather as an interventional modality within clinical immunology/hematology.

Other names
PlasmapheresisTherapeutic plasma exchangePlasma apheresisPathogenic antibody removal via plasmapheresis
02

Mechanism of action

The mechanism is physical removal of circulating pathogenic substances such as autoantibodies, immune complexes, paraproteins, and toxins from the patient’s plasma using extracorporeal separation techniques.

03

Biological functions

Removal of pathogenic antibodies from circulationImmune modulation by depleting autoantibodies and immune complexesReduction of inflammatory mediators and toxins in blood
04

Disease associations

Autoimmune disease management (e.g., myasthenia gravis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy)Neurological disease crisis interventionRenal diseases with antibody-mediated pathologyHematological disorders involving abnormal proteins or antibodies
05

Safety considerations

Allergic reactions to replacement fluids or adsorption columnsHypotension during the procedure due to fluid shiftsRisk of infection due to venous access devicesCoagulation disturbances if clotting factors are depleted excessively

Beyond the preview

Go deeper on Plasma exchange (plasmapheresis) for pathogenic antibody removal (PE (for plasma exchange), sometimes TPE (therapeutic plasma exchange)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma exchange (plasmapheresis) for pathogenic antibody removal (PE (for plasma exchange), sometimes TPE (therapeutic plasma exchange)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call